PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $481 | +13.7% | 11,993 | +15.8% | 0.00% | 0.0% |
| Q1 2023 | $423 | -99.9% | 10,355 | -17.3% | 0.00% | -66.7% |
| Q3 2022 | $666,000 | -32.3% | 12,515 | -3.0% | 0.00% | -25.0% |
| Q1 2022 | $984,000 | +55.5% | 12,898 | +22.6% | 0.00% | +100.0% |
| Q4 2021 | $633,000 | -72.7% | 10,517 | -72.7% | 0.00% | -86.7% |
| Q3 2020 | $2,316,000 | +20.5% | 38,528 | +5.2% | 0.02% | +15.4% |
| Q2 2020 | $1,922,000 | +167.7% | 36,634 | +71.1% | 0.01% | +116.7% |
| Q1 2020 | $718,000 | – | 21,406 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |